WallStreetZenWallStreetZen

NASDAQ: MYGN
Myriad Genetics Inc Stock Ownership - Who owns Myriad Genetics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Myriad Genetics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jennifer Lynne FoxChief Legal Officer2025-09-034,435$6.80
$30.16kSell
Samraat S. RahaPresident and CEO2025-05-311,498$3.56
$5.34kBuy
Dale MuzzeyChief Scientific Officer2025-04-14942$8.08
$7.61kSell
Mark VerrattiChief Commercial Officer2025-04-141,085$8.08
$8.77kSell
Natalie MunkChief Accounting Officer2025-03-25362$9.73
$3.52kSell
Dale MuzzeyChief Scientific Officer2025-03-24545$9.98
$5.44kSell
Dale MuzzeyChief Scientific Officer2025-03-24800$9.98
$7.98kSell
Paul J. DiazPresident and CEO2025-03-2418,312$9.98
$182.75kSell
Paul J. DiazPresident and CEO2025-03-2426,827$9.98
$267.73kSell
Natalie MunkChief Accounting Officer2025-03-24589$9.98
$5.88kSell

1 of 6

MYGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MYGN insiders and whales buy or sell their stock.

MYGN Shareholders

What type of owners hold Myriad Genetics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc16.20%15,072,259$113.04MInstitution
Vanguard Group Inc9.95%9,257,493$69.43MInstitution
Millennium Management LLC5.29%4,924,714$36.94MInstitution
State Street Corp5.17%4,809,949$36.07MInstitution
Glenview Capital Management LLC4.93%4,587,407$34.41MInstitution
Morgan Stanley4.89%4,554,080$34.16MInstitution
D E Shaw Co Inc4.85%4,511,497$33.84MInstitution
Geode Capital Management LLC2.39%2,222,962$16.67MInstitution
Dimensional Fund Advisors LP2.23%2,073,218$15.55MInstitution
Qube Research Technologies Ltd2.20%2,051,588$15.39MInstitution

1 of 3

MYGN vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MYGN91.33%8.67%Net SellingNet Selling
FLGT53.12%42.23%Net SellingNet Selling
CSTL85.56%14.44%Net SellingNet Selling
CDNA78.09%21.91%Net SellingNet Selling
LAB54.17%45.83%Net BuyingNet Buying
View Top Diagnostic & Research Stocks

Myriad Genetics Stock Ownership FAQ

Who owns Myriad Genetics?

Myriad Genetics (NASDAQ: MYGN) is owned by 97.26% institutional shareholders, 9.23% Myriad Genetics insiders, and 0.00% retail investors. Paul J. Diaz is the largest individual Myriad Genetics shareholder, owning 891,844.00 shares representing 0.96% of the company. Paul J. Diaz's Myriad Genetics shares are currently valued at $6.60M.

If you're new to stock investing, here's how to buy Myriad Genetics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.